Company Monitoring Page for Vivus

latest headlines for company on cafepharma

Arena Wins!
Seeking Alpha
Fri, 12/28/12 - 11:38 am
Tags:
Arena Pharmaceuticals, Orexigen, Vivus, Belviq, Contrave, Qsymia
Key Dates For Arena And Orexigen Investors
Seeking Alpha
Wed, 12/26/12 - 09:25 pm
Tags:
Orexigen, Contrave, Belviq, Arena Pharmaceuticals, Qsymia, Vivus, obesity
Drug Approvals Are Priced In, Wait For The Buying Opportunity
Seeking Alpha
Mon, 12/24/12 - 10:32 am
Tags:
drug approvals, Arena Pharmaceuticals, Vivus, NPS Pharmaceuticals, Alexza
Does Qsymia Have a Future After All?
Wall Street Cheat Street
Sat, 12/22/12 - 12:26 pm
Tags:
Qsymia, weight loss, obesity, Vivus
Vivus Rises On Wider Coverage Of Qsymia
Seeking Alpha
Fri, 12/21/12 - 10:25 am
Tags:
Qsymia, Vivus, obesity
Vivus, Dendreon Set To Rally From The January Effect
Seeking Alpha
Wed, 12/19/12 - 01:35 pm
Tags:
Dendreon, Vivus, Provenge, Qsymia
Vivus shares jump on strong growth in Qsymia prescriptions
Reuters
Mon, 12/17/12 - 01:21 pm
Tags:
Vivus, Qsymia, obesity
Investor Enthusiasm Wanes For Obesity Drug Companies
Seeking Alpha
Sun, 12/16/12 - 11:01 am
Tags:
weight loss, obesity, Arena Pharmaceuticals, Belviq, Vivus, Qsymia
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Tags:
Xtandi, Medivation, prostate cancer, Stribild, Gilead Sciences, HIV, Belviq, Arena Pharmaceuticals, obesity, weight loss, Qsymia, Vivus, Kyprolis, ONYX Pharmaceuticals, Multiple Myeloma, Omontys, Affymax, anemia, Linzess, irritable bowel syndrome, Ironwood Pharmaceuticals, Bosulif, chronic myeloid leukemia, Pfizer, Amyvid, Alzheimer's disease, Eli Lilly, Eylea, macular degeneration, Regeneron
3 Biopharmaceuticals Weighed By Uncertainty
Seeking Alpha
Fri, 12/7/12 - 10:56 am
Tags:
Vivus, Orexigen, obesity, Arena Pharmaceuticals
Vivus Initiates Free Trial - May Boost Sales
Seeking Alpha
Tue, 11/27/12 - 11:15 am
Tags:
Vivus, Qsymia
Fat Chance: The Vivus Diet Pill Has Skinny Sales
Pharmalot
Tue, 11/27/12 - 10:33 am
Tags:
Vivus, obesity, Qsymia
This Week in Biotech
Motley Fool
Sun, 11/25/12 - 11:15 am
Tags:
Arena, Vivus, Regeneron, Sanofi, MAP Pharmaceuticals, Allergan
Good News for Vivus and Arena
Motley Fool
Sat, 11/24/12 - 11:37 am
Tags:
Vivus, Arena, weight loss, obesity
Picking The Weight Loss Winner In The Arena Vs. Vivus War
Seeking Alpha
Mon, 11/19/12 - 11:16 am
Tags:
Arena Pharmaceuticals, Vivus, Belviq, Qsymia
What Are the Biggest Risks Facing VIVUS Today?
Motley Fool
Sat, 11/17/12 - 01:52 pm
Tags:
Vivus
Vivus’ Problems are Arena's Opportunities
Motley Fool
Fri, 11/16/12 - 10:33 am
Tags:
Vivus, Arena Pharmaceuticals, obesity, Qsymia, Belviq
Are Arena and VIVUS Frenemies?
Motley Fool
Thu, 11/15/12 - 04:36 pm
Tags:
Arena Pharmaceuticals, Vivus, Qsymia, Belviq, obesity
VIVUS finds improvements in patients with OSA treated with Qsymia
The Fly on the Wall
Mon, 11/12/12 - 11:40 am
Tags:
Vivus, obstructive sleep apnea, Qsymia
Biotech Weekend Recap: Important Developments And Big Releases
Seeking Alpha
Sun, 11/11/12 - 09:49 am
Tags:
Amarin, Vivus, Dendreon, Arena Pharmaceuticals, Pharmacyclics, Biomarin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.